Dipti Talaulikar is a Hematologist-Oncologist based in Canberra, ACT, Australia. She looks after people with a range of blood cancers and blood-related conditions, usually at times when things feel confusing and scary. In the clinic, she focuses on clear explanations and steady follow-up, so patients know what is happening and what comes next.
Her work covers many different types of lymphomas and leukaemias. This can include B-cell lymphomas such as DLBCL, follicular lymphoma, mantle cell lymphoma, and marginal zone lymphoma. She also treats Hodgkin lymphoma, including classical Hodgkin lymphoma, as well as some less common forms like NLPHL. At times, she manages Waldenström macroglobulinaemia and other lymphoma-related conditions that can affect the immune system and blood function.
Dipti also supports people with broader blood and marrow problems. This includes conditions like chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL), and chronic B-cell leukaemia (CBCL). She may also be involved in care for myelodysplastic syndrome (MDS) and other blood disorders where the bone marrow is not working as it should.
Where treatment needs involve the immune system and the whole body, she helps guide care for issues such as secondary immunodeficiency. She also works with rarer inflammatory and blood conditions, including haemophagocytic lymphohistiocytosis (HLH) and histiocytosis. In some cases, this care can be complex, so being organised and calm matters a lot.
Treatment can include bone marrow transplant care and tissue biopsy work, depending on what has been found and what the best next step looks like. She helps coordinate the pathway from tests through to treatment planning, and keeps an eye on how people respond over time. For some patients, that means careful monitoring and managing side effects, not just the main treatment.
Dipti keeps up with new findings in the field through medical publications, and she aims to use what is supported by current evidence. Clinical trials can also be part of the conversation for some patients, if they fit the situation and are available.
Overall, she is there to support patients through diagnosis, treatment, and follow-up for blood cancers and related conditions, with a practical, plain-language approach.
